Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.43 USD | -0.73% | -2.96% | -8.35% |
03:44pm | Baxter International's Clinolipid Injection Approved for Expanded Use in US | MT |
May. 10 | TD Cowen Downgrades Baxter International to Hold From Buy, Price Target is $40 | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.35% | 18.19B | |
-4.82% | 182B | |
+1.38% | 110B | |
-2.82% | 68.11B | |
+0.69% | 50.53B | |
+8.54% | 44.8B | |
+2.84% | 40.7B | |
+20.50% | 32.25B | |
+1.72% | 26.53B | |
+15.25% | 25.02B |
- Stock Market
- Equities
- BAX Stock
- News Baxter International Inc.
- Transcript : Baxter International Inc. Presents at Jefferies 2023 Global Healthcare Conference, Jun-08-2023 10